The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ARROWHEAD PHARMACEUTICALS IN | COM | 04280A100 | 1,751,726 | 67,400 | SH | SOLE | 67,400 | 0 | 0 | ||
BRIDGEBIO PHARMA INC | COM | 10806X102 | 3,069,996 | 121,200 | SH | SOLE | 121,200 | 0 | 0 | ||
CURIS INC | COM | 231269309 | 2,911,462 | 421,951 | SH | SOLE | 421,951 | 0 | 0 | ||
FRACTYL HEALTH INC | COM | 35168W103 | 7,925,620 | 1,856,117 | SH | SOLE | 1,856,117 | 0 | 0 | ||
INVIVYD INC | COM | 00534A102 | 10,173,075 | 9,248,250 | SH | SOLE | 9,248,250 | 0 | 0 | ||
PROQR THRAPEUTICS N V | SHS EURO | N71542109 | 1,692,367 | 1,019,498 | SH | SOLE | 1,019,498 | 0 | 0 | ||
ROCKET PHARMACEUTICALS INC | COM | 77313F106 | 8,303,690 | 385,680 | SH | SOLE | 385,680 | 0 | 0 | ||
SILENCE THERAPEUTICS PLC | ADS | 82686Q101 | 3,516,900 | 185,100 | SH | SOLE | 185,100 | 0 | 0 | ||
SPRINGWORKS THERAPEUTICS INC | COM | 85205L107 | 4,158,768 | 110,400 | SH | SOLE | 110,400 | 0 | 0 | ||
TG THERAPEUTICS INC | COM | 88322Q108 | 2,874,864 | 161,600 | SH | SOLE | 161,600 | 0 | 0 | ||
WAVE LIFE SCIENCES LTD | SHS | Y95308105 | 30,761,095 | 6,164,548 | SH | SOLE | 6,164,548 | 0 | 0 |